rdf:type |
|
lifeskim:mentions |
umls-concept:C0019693,
umls-concept:C0034656,
umls-concept:C0043474,
umls-concept:C0231221,
umls-concept:C0282116,
umls-concept:C0332167,
umls-concept:C0585361,
umls-concept:C0599724,
umls-concept:C0681850,
umls-concept:C1257890,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1836233,
umls-concept:C2349001,
umls-concept:C2603343,
umls-concept:C2697811
|
pubmed:issue |
3
|
pubmed:dateCreated |
1994-8-16
|
pubmed:abstractText |
To evaluate the efficacy of zidovudine given twice daily in subjects with asymptomatic HIV-1 infection and a high risk of progression to AIDS.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
313-21
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7913326-AIDS-Related Complex,
pubmed-meshheading:7913326-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:7913326-CD4-Positive T-Lymphocytes,
pubmed-meshheading:7913326-Double-Blind Method,
pubmed-meshheading:7913326-Europe,
pubmed-meshheading:7913326-Female,
pubmed-meshheading:7913326-HIV Core Protein p24,
pubmed-meshheading:7913326-HIV Infections,
pubmed-meshheading:7913326-HIV-1,
pubmed-meshheading:7913326-Humans,
pubmed-meshheading:7913326-Leukocyte Count,
pubmed-meshheading:7913326-Male,
pubmed-meshheading:7913326-Patient Compliance,
pubmed-meshheading:7913326-Risk Factors,
pubmed-meshheading:7913326-Safety,
pubmed-meshheading:7913326-Time Factors,
pubmed-meshheading:7913326-Zidovudine
|
pubmed:year |
1994
|
pubmed:articleTitle |
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)
|
pubmed:affiliation |
Slotervaatziekenhuis, Department of Internal Medicine, Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|